$4.07
-0.07-1.69%
At close: -
$4.05
-0.02-0.49%
After Hours: Mar 7, 6:01 PM EDT
Comments
Loading...
4D Molecular Therapeutics Stock Guidance | NASDAQ:FDMT | Benzinga
4D Molecular Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for 4D Molecular Therapeutics (FDMT)?
There have been no specific sales or earnings guidance reported for 4D Molecular Therapeutics in recent months.
Browse guidance and forecast on all stocks.